Formosa Laboratories, Inc. — Investor Relations & Filings
Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 115年4月背書保證與資金貸與 | 2026-05-05 | Chinese | |
| 115年4月營業收入 | 2026-05-05 | Chinese | |
| 115年04月內部人持股異動(事後) | 2026-05-05 | Chinese | |
| 115年04月董事會成員及持股 | 2026-05-05 | Chinese | |
| 115年3月背書保證與資金貸與 | 2026-04-07 | Chinese | |
| 115年3月營業收入 | 2026-04-07 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41307872 | 115年4月背書保證與資金貸與 | 2026-05-05 | Chinese | ||
| 41307862 | 115年4月營業收入 | 2026-05-05 | Chinese | ||
| 41459812 | 115年04月內部人持股異動(事後) | 2026-05-05 | Chinese | ||
| 41457459 | 115年04月董事會成員及持股 | 2026-05-05 | Chinese | ||
| 33701037 | 115年3月背書保證與資金貸與 | 2026-04-07 | Chinese | ||
| 33700994 | 115年3月營業收入 | 2026-04-07 | Chinese | ||
| 33700947 | 115年03月內部人持股異動(事後) | 2026-04-07 | Chinese | ||
| 33700708 | 115年03月董事會成員及持股 | 2026-04-07 | Chinese | ||
| 34617719 | 114年度財務比率 | 2026-03-25 | Chinese | ||
| 34617720 | 114年第4季海外子公司投資 | 2026-03-25 | Chinese | ||
| 34617721 | 114年第4季大陸投資 | 2026-03-25 | Chinese | ||
| 34617722 | 補正本公司114年第四季合併及個體財務報表附註 | 2026-03-18 | Chinese | ||
| 34617726 | 115年03月法人說明會簡報 — 474620260313E001.pdf | 2026-03-13 | Chinese | ||
| 34617725 | 115年03月法人說明會簡報 — 474620260313M001.pdf | 2026-03-13 | Chinese | ||
| 34617723 | 115年03月法人說明會簡報 | 2026-03-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bicara Therapeutics Inc.
Clinical-stage biopharma developing dual-action biologics f…
|
BCAX | US | Manufacturing |
|
BICYCLE THERAPEUTICS PLC
Clinical-stage biopharma developing a novel class of bicycl…
|
BCYC | GB | Manufacturing |
|
BIFIDO. Co. Ltd
Biotechnology firm developing human-derived Bifidobacterium…
|
238200 | KR | Manufacturing |
|
Binex Co., Ltd.
Biopharmaceutical firm with pharma manufacturing and biolog…
|
053030 | KR | Manufacturing |
|
BioAge Labs, Inc.
A clinical-stage biotech developing therapies for metabolic…
|
BIOA | US | Manufacturing |
|
Bioasis Technologies Inc.
Developing the xB3 platform to deliver therapeutics across …
|
BIOAF | CA | Manufacturing |
|
BioAtla, Inc.
Develops antibody-based therapeutics activated within the t…
|
BCAB | US | Manufacturing |
|
BIOBIJOU Co., Ltd.
Develops and manufactures medical aesthetic products like H…
|
489460 | KR | Manufacturing |
|
BioCardia, Inc.
Develops cell-derived therapeutics for cardiovascular and p…
|
BCDA | US | Manufacturing |
|
Biocartis Group NV
Develops and commercializes an automated molecular diagnost…
|
BCART | BE | Manufacturing |
Formosa Laboratories, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52425/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52425 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52425 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52425 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52425}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Formosa Laboratories, Inc. (id: 52425)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.